23andMe Holding Co.·4

Mar 11, 4:09 PM ET

HIBBS KATHY L 4

4 · 23andMe Holding Co. · Filed Mar 11, 2024

Insider Transaction Report

Form 4
Period: 2024-03-07
HIBBS KATHY L
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-03-0738,548154,195 total
    Exercise: $0.42Exp: 2024-05-04Class A Common Stock (38,548 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2024-03-07$0.42/sh+38,548$16,1901,290,863 total
  • Sale

    Class A Common Stock

    2024-03-07$0.53/sh38,548$20,4301,252,315 total
Footnotes (4)
  • [F1]Includes 12,488 shares acquired under the 23andMe Holding Co. 2021 Employee Stock Purchase Plan on February 29, 2024.
  • [F2]The sale reported on this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 9, 2023.
  • [F3]The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $0.5035 to $0.5580. Upon request by the staff of the Securities and Exchange commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
  • [F4]The stock options vested 25% after 12 months of service and on a pro rata basis (in remaining 1/48 installments) over the following 36 months of service beginning on April 1, 2014.

Documents

1 file
  • 4
    wk-form4_1710187770.xmlPrimary

    FORM 4